Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01163331 · ClinicalTrials.gov registry record · NA
Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment
A NA study of Voice Quality and Voice Loudness Associated With Parkinson's Disease, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01163331 is a NA study of Voice Quality and Voice Loudness Associated With Parkinson's Disease that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01163331, a NA study of Voice Quality and Voice Loudness Associated With Parkinson's Disease, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare group singing to group speech therapy without singing. You may be eligible for this study if you have been diagnosed with PD for one year or more and you have a quiet voice or difficulty being understood.
Conditions Studied
Interventions
- OTHER Singing Therapy
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01163331
The ClinicalTrials.gov registry entry for NCT01163331 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Voice Quality and Voice Loudness Associated With Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Singing Therapy is the first listed.
NCT01163331 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01163331 about?
NCT01163331 is a clinical study titled "Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment". This study will compare group singing to group speech therapy without singing. You may be eligible for this study if you have been diagnosed with PD for one year or more and you have a quiet voice or difficulty being understood.
What is the current status of trial NCT01163331?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-03.
What conditions does trial NCT01163331 study?
This clinical trial studies the following conditions: Voice Quality and Voice Loudness Associated With Parkinson's Disease.
What interventions are being tested in trial NCT01163331?
The interventions under investigation include: Singing Therapy (OTHER).
Who is sponsoring clinical trial NCT01163331?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01163331 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.